Baird Financial Group’s Juno Therapeutics, Inc. JUNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-5,677
| Closed | -$259K | – | 1333 |
|
|
2017
Q4 | $259K | Sell |
5,677
-1,650
| -23% | -$75.3K | ﹤0.01% | 1160 |
|
|
2017
Q3 | $329K | Sell |
7,327
-5,060
| -41% | -$227K | ﹤0.01% | 1088 |
|
|
2017
Q2 | $370K | Sell |
12,387
-16,196
| -57% | -$484K | ﹤0.01% | 1039 |
|
|
2017
Q1 | $634K | Buy |
28,583
+5,839
| +26% | +$130K | 0.01% | 894 |
|
|
2016
Q4 | $429K | Sell |
22,744
-857
| -4% | -$16.2K | ﹤0.01% | 961 |
|
|
2016
Q3 | $708K | Buy |
23,601
+11,134
| +89% | +$334K | 0.01% | 844 |
|
|
2016
Q2 | $359K | Buy |
12,467
+4,587
| +58% | +$132K | ﹤0.01% | 1007 |
|
|
2016
Q1 | $300K | Buy |
7,880
+3,185
| +68% | +$121K | ﹤0.01% | 1052 |
|
|
2015
Q4 | $206K | Sell |
4,695
-1,080
| -19% | -$47.4K | ﹤0.01% | 1159 |
|
|
2015
Q3 | $235K | Buy |
+5,775
| New | +$235K | ﹤0.01% | 1117 |
|